Nirvana Life Sciences Inc. (CSE:NIRV)
Canada flag Canada · Delayed Price · Currency is CAD
0.1050
-0.1950 (-65.00%)
Apr 1, 2025, 5:05 PM EST

Nirvana Life Sciences Cash Flow Statement

Millions CAD. Fiscal year is May - Apr.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jan '25 Apr '24 Apr '23 Apr '22 Apr '21
Net Income
-0.54-0.87-1.49-5.65-0.73
Depreciation & Amortization
0.010.020.090.090.03
Asset Writedown & Restructuring Costs
0.160.160.25--
Stock-Based Compensation
0.030.180.2--
Provision & Write-off of Bad Debts
---0.32-
Other Operating Activities
-0-0.030.234.480.08
Change in Accounts Payable
-0.010.030.05-0.10.02
Change in Other Net Operating Assets
0.310.330.320.38-0.05
Operating Cash Flow
-0.05-0.19-0.33-0.49-0.65
Capital Expenditures
-----0.55
Cash Acquisitions
---0.11-
Other Investing Activities
----0.21-0.12
Investing Cash Flow
----0.1-0.67
Short-Term Debt Issued
-0.030.050-
Total Debt Issued
00.030.050-
Net Debt Issued (Repaid)
-0.030.030.050-
Issuance of Common Stock
-0.150.26-2.09
Other Financing Activities
0.01----0.02
Financing Cash Flow
-0.080.180.3102.07
Net Cash Flow
-0.01-0.01-0.02-0.590.75
Free Cash Flow
-0.05-0.19-0.33-0.49-1.2
Free Cash Flow Per Share
-0.01-0.04-0.10-0.13-0.35
Levered Free Cash Flow
0.05-0.03-0.090.03-
Unlevered Free Cash Flow
0.05-0.03-0.080.03-
Change in Net Working Capital
-0.25-0.22-0.35-0.67-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.